Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock

Ali Ghodsizad, Kai Singbartl, Matthias Loebe, Mohamed Zeriouh, Arjang Ruhparwar, April Grant, Ali El-Banayosy, M. M. Koerner

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 %, and the one year survival for patients with non-ischemic heart disease was 75%.

Original languageEnglish (US)
Pages (from-to)E274-E277
JournalHeart Surgery Forum
Volume20
Issue number6
DOIs
StatePublished - Dec 1 2017

Fingerprint

Extracorporeal Membrane Oxygenation
Cardiogenic Shock
Myocardial Ischemia
Heart Diseases
Survival Rate
Survival
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Ghodsizad, A., Singbartl, K., Loebe, M., Zeriouh, M., Ruhparwar, A., Grant, A., ... Koerner, M. M. (2017). Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock. Heart Surgery Forum, 20(6), E274-E277. https://doi.org/10.1532/hsf.1635

Extracorporeal membrane oxygenation (ECMO) : An option for cardiac reccovery from advanced cardiogenic shock. / Ghodsizad, Ali; Singbartl, Kai; Loebe, Matthias; Zeriouh, Mohamed; Ruhparwar, Arjang; Grant, April; El-Banayosy, Ali; Koerner, M. M.

In: Heart Surgery Forum, Vol. 20, No. 6, 01.12.2017, p. E274-E277.

Research output: Contribution to journalArticle

Ghodsizad, A, Singbartl, K, Loebe, M, Zeriouh, M, Ruhparwar, A, Grant, A, El-Banayosy, A & Koerner, MM 2017, 'Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock', Heart Surgery Forum, vol. 20, no. 6, pp. E274-E277. https://doi.org/10.1532/hsf.1635
Ghodsizad, Ali ; Singbartl, Kai ; Loebe, Matthias ; Zeriouh, Mohamed ; Ruhparwar, Arjang ; Grant, April ; El-Banayosy, Ali ; Koerner, M. M. / Extracorporeal membrane oxygenation (ECMO) : An option for cardiac reccovery from advanced cardiogenic shock. In: Heart Surgery Forum. 2017 ; Vol. 20, No. 6. pp. E274-E277.
@article{866d1c6b1d1e4498a29e3954fd0e8573,
title = "Extracorporeal membrane oxygenation (ECMO): An option for cardiac reccovery from advanced cardiogenic shock",
abstract = "Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 {\%}, and the one year survival for patients with non-ischemic heart disease was 75{\%}.",
author = "Ali Ghodsizad and Kai Singbartl and Matthias Loebe and Mohamed Zeriouh and Arjang Ruhparwar and April Grant and Ali El-Banayosy and Koerner, {M. M.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1532/hsf.1635",
language = "English (US)",
volume = "20",
pages = "E274--E277",
journal = "Heart Surgery Forum",
issn = "1098-3511",
publisher = "Carden Jennings Publishing Co. Ltd",
number = "6",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation (ECMO)

T2 - An option for cardiac reccovery from advanced cardiogenic shock

AU - Ghodsizad, Ali

AU - Singbartl, Kai

AU - Loebe, Matthias

AU - Zeriouh, Mohamed

AU - Ruhparwar, Arjang

AU - Grant, April

AU - El-Banayosy, Ali

AU - Koerner, M. M.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 %, and the one year survival for patients with non-ischemic heart disease was 75%.

AB - Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 %, and the one year survival for patients with non-ischemic heart disease was 75%.

UR - http://www.scopus.com/inward/record.url?scp=85050191719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050191719&partnerID=8YFLogxK

U2 - 10.1532/hsf.1635

DO - 10.1532/hsf.1635

M3 - Article

C2 - 29272229

AN - SCOPUS:85050191719

VL - 20

SP - E274-E277

JO - Heart Surgery Forum

JF - Heart Surgery Forum

SN - 1098-3511

IS - 6

ER -